Yearly lenacapavir injection for HIV prevention shows safety and long-lasting effects, according to clinical trial results.

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Years of evidence have indicated that the Church has contributed to the spread of misinformation and HIV-related ...

There were empty seats in San Francisco last week at an annual international science conference that has delivered some of the world's most groundbreaking HIV research. It was a throwback to another ...

The national health department has tried to reassure the public that the country’s HIV response is mostly funded by the ...

In 2023, after a brief hiatus, tuberculosis regained from COVID its status as the world’s deadliest infectious disease—a ...

After the US slashed global aid, the South African government stated that only 17% of its HIV spending relied on US funding.

An annual shot to protect against HIV infection has successfully passed an early safety trial, according to research ...

Mayor Daniel Lurie signed an executive order aimed at consolidating services he thinks are not doing enough to help the ...

While poppers have previously been incorrectly linked to AIDS in the LGBTQ+ community — an unfounded stance Robert F. Kennedy ...

Donald Trump Jr. and his girlfriend, Bettina Anderson, smiled while posing for red carpet pics at the 2025 amfAR Palm Beach ...

IIT Roorkee researchers have discovered that Efavirenz, an HIV drug, may help treat Chikungunya by reducing virus replication in lab tests and mice models. While promising, clinical trials are needed ...